KR20240008831A - 2차 막 제거를 위한 체외 장치 및 방법 - Google Patents
2차 막 제거를 위한 체외 장치 및 방법 Download PDFInfo
- Publication number
- KR20240008831A KR20240008831A KR1020237034947A KR20237034947A KR20240008831A KR 20240008831 A KR20240008831 A KR 20240008831A KR 1020237034947 A KR1020237034947 A KR 1020237034947A KR 20237034947 A KR20237034947 A KR 20237034947A KR 20240008831 A KR20240008831 A KR 20240008831A
- Authority
- KR
- South Korea
- Prior art keywords
- blood
- dialysate
- chamber
- mode
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 127
- 238000000034 method Methods 0.000 title claims abstract description 89
- 238000000338 in vitro Methods 0.000 title claims description 5
- 239000008280 blood Substances 0.000 claims abstract description 381
- 210000004369 blood Anatomy 0.000 claims abstract description 381
- 238000011282 treatment Methods 0.000 claims abstract description 100
- 230000008569 process Effects 0.000 claims abstract description 20
- 238000012546 transfer Methods 0.000 claims abstract description 14
- 239000012530 fluid Substances 0.000 claims description 116
- 238000006073 displacement reaction Methods 0.000 claims description 113
- 238000012545 processing Methods 0.000 claims description 108
- 238000000108 ultra-filtration Methods 0.000 claims description 81
- 239000003607 modifier Substances 0.000 claims description 65
- 238000012937 correction Methods 0.000 claims description 42
- 230000017531 blood circulation Effects 0.000 claims description 38
- 238000009825 accumulation Methods 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 16
- 230000036770 blood supply Effects 0.000 claims description 14
- 230000037452 priming Effects 0.000 claims description 14
- 238000005534 hematocrit Methods 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 5
- 238000005086 pumping Methods 0.000 claims description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 5
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000002679 ablation Methods 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000003672 processing method Methods 0.000 claims 1
- 230000008859 change Effects 0.000 description 33
- 238000010790 dilution Methods 0.000 description 19
- 239000012895 dilution Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 17
- 238000001631 haemodialysis Methods 0.000 description 16
- 230000000322 hemodialysis Effects 0.000 description 16
- 238000002615 hemofiltration Methods 0.000 description 16
- 230000009467 reduction Effects 0.000 description 13
- 230000003247 decreasing effect Effects 0.000 description 11
- 238000011144 upstream manufacturing Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000007257 malfunction Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000009285 membrane fouling Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108010050608 Myocardial Depressant Factor Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
- A61M1/3644—Mode of operation
- A61M1/365—Mode of operation through membranes, e.g. by inverted trans-membrane pressure [TMP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1621—Constructional aspects thereof
- A61M1/1635—Constructional aspects thereof with volume chamber balancing devices between used and fresh dialysis fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3455—Substitution fluids
- A61M1/3465—Substitution fluids using dialysate as substitution fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3479—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by dialysing the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
- A61M2205/7554—General characteristics of the apparatus with filters with means for unclogging or regenerating filters
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188624P | 2021-05-14 | 2021-05-14 | |
| US63/188,624 | 2021-05-14 | ||
| PCT/US2022/022141 WO2022240488A1 (en) | 2021-05-14 | 2022-03-28 | Extracorporeal device and method for removal of secondary membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240008831A true KR20240008831A (ko) | 2024-01-19 |
Family
ID=84029785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237034947A Pending KR20240008831A (ko) | 2021-05-14 | 2022-03-28 | 2차 막 제거를 위한 체외 장치 및 방법 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11938258B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313206A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024517095A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240008831A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117279678A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3209997A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE22807994T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022240488A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141493A (en) * | 1990-01-26 | 1992-08-25 | Sarcos Group | Peritoneal dialysis system |
| DE4239937C2 (de) * | 1992-11-27 | 1995-08-24 | Fresenius Ag | Verfahren zur Feststellung der Funktionsfähigkeit einer Teileinrichtung eines Hämodialysegerätes und Vorrichtung zur Durchführung dieses Verfahrens |
| US6726647B1 (en) * | 1998-10-23 | 2004-04-27 | Gambro Ab | Method and device for measuring access flow |
| US6423231B1 (en) * | 1998-10-30 | 2002-07-23 | Nephros, Inc. | Non-isosmotic diafiltration system |
| JP4457235B2 (ja) * | 2001-12-18 | 2010-04-28 | 株式会社北九州バイオフィジックス研究所 | 自動血液透析装置および該装置を使用したプライミング方法。 |
| JP4250712B2 (ja) * | 2002-06-19 | 2009-04-08 | 株式会社北九州バイオフィジックス研究所 | 自動血液透析装置 |
| US8029454B2 (en) * | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
| WO2005107833A1 (en) * | 2004-05-07 | 2005-11-17 | Gambro Lundia Ab | Blood treatment equipment, method and software program for controlling infusion. |
| DE102009058681A1 (de) * | 2009-12-16 | 2011-06-22 | Fresenius Medical Care Deutschland GmbH, 61352 | Bilanziereinrichtung, externe medizinische Funktionseinrichtung, Behandlungsvorrichtung sowie Verfahren |
| DE102011008329B4 (de) * | 2011-01-11 | 2012-09-27 | Fresenius Medical Care Deutschland Gmbh | Blutbehandlungseinheit für eine extrakorporale Blutbehandlungsvorrichtung |
| US9750862B2 (en) * | 2011-04-29 | 2017-09-05 | Medtronic, Inc. | Adaptive system for blood fluid removal |
| DE102013021012A1 (de) | 2013-12-13 | 2015-06-18 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung zur extrakorporalen Blutbehandlung |
| US20170021075A1 (en) * | 2015-07-21 | 2017-01-26 | Fresenius Medical Care Holdings, Inc. | Mid-dilution hemodiafiltration with multi-line dialysate supply |
| DE102016001478A1 (de) * | 2016-02-10 | 2017-08-24 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung zur extrakorporalen Blutbehandlung und Verfahren zum Betreiben einer Vorrichtung zur extrakorporalen Blutbehandlung |
| DE102016107024A1 (de) * | 2016-04-15 | 2017-10-19 | B. Braun Avitum Ag | Verfahren und Vorrichtung zur extrakorporalen Blutbehandlung |
| DE102016008755B4 (de) * | 2016-07-18 | 2024-06-06 | Fresenius Medical Care Deutschland Gmbh | Dialysegerät mit einer Steuereinheit zur Durchführung einer Konditionierung der Dialysemembran |
| DE102017000227A1 (de) * | 2017-01-13 | 2018-07-19 | Fresenius Medical Care Deutschland Gmbh | Extrakorporale Blutbehandlungsvorrichtung und Verfahren zur Überwachung der Integrität eines Dialysators einer extrakorporalen Blutbehandlungsvorrichtung |
| CN110809802B (zh) * | 2017-06-28 | 2024-06-18 | 甘布罗伦迪亚股份公司 | 用于肾脏替代治疗的系统和方法 |
-
2022
- 2022-03-28 WO PCT/US2022/022141 patent/WO2022240488A1/en not_active Ceased
- 2022-03-28 EP EP22807994.3A patent/EP4313206A4/en active Pending
- 2022-03-28 DE DE22807994.3T patent/DE22807994T1/de active Pending
- 2022-03-28 JP JP2023563056A patent/JP2024517095A/ja active Pending
- 2022-03-28 CA CA3209997A patent/CA3209997A1/en active Pending
- 2022-03-28 KR KR1020237034947A patent/KR20240008831A/ko active Pending
- 2022-03-28 US US17/705,574 patent/US11938258B2/en active Active
- 2022-03-28 CN CN202280028440.0A patent/CN117279678A/zh active Pending
-
2024
- 2024-02-27 US US18/588,284 patent/US12478717B2/en active Active
-
2025
- 2025-09-05 US US19/320,274 patent/US20260000819A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220370699A1 (en) | 2022-11-24 |
| US20240197975A1 (en) | 2024-06-20 |
| CN117279678A (zh) | 2023-12-22 |
| WO2022240488A1 (en) | 2022-11-17 |
| US12478717B2 (en) | 2025-11-25 |
| DE22807994T1 (de) | 2024-06-13 |
| JP2024517095A (ja) | 2024-04-19 |
| US11938258B2 (en) | 2024-03-26 |
| US20260000819A1 (en) | 2026-01-01 |
| EP4313206A1 (en) | 2024-02-07 |
| CA3209997A1 (en) | 2022-11-17 |
| EP4313206A4 (en) | 2025-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101131343B1 (ko) | 혈액 처리 기기, 주입 제어 방법 및 주입 제어용 소프트웨어 프로그램 | |
| JP5587891B2 (ja) | 体外での血液処理のための装置及び前記装置を管理する方法 | |
| JP4643642B2 (ja) | 血液の体外処理のための装置及び方法 | |
| EP2404629B1 (en) | Apparatus for controlling an extra-corporeal blood treatment in a medical device | |
| US10960119B2 (en) | Method for operating a blood treatment apparatus, control unit and treatment apparatus for executing the method | |
| US11116883B2 (en) | Method for removing blood from an extracorporeal blood circuit after completing a blood treatment session, control and regulating unit and treatment apparatus for executing the method | |
| CN101945677B (zh) | 血量监测器与血液治疗设备 | |
| KR20150058239A (ko) | 체외 혈액 치료 중 재순환을 검출하는 장치 및 방법 | |
| EP3015124B1 (en) | System for flexible citrate anticoagulation during extracorporeal blood treatment using feed-forward control | |
| JP6070348B2 (ja) | 血液透析装置 | |
| US11992588B2 (en) | Blood hose set, a control device or closed-loop control device, a blood treatment apparatus and a method for the single-needle treatment | |
| JP6812340B2 (ja) | 体外血液回路のフラッシング方法 | |
| WO2017159872A1 (ja) | 血液透析装置及び制御プログラム | |
| US11975130B2 (en) | System and a method for renal replacement therapy | |
| JP7615778B2 (ja) | 血液浄化装置 | |
| US12478717B2 (en) | Extracorporeal device and method for removal of secondary membrane | |
| HK40101032A (en) | Extracorporeal device and method for removal of secondary membrane | |
| JP7725878B2 (ja) | 血液浄化装置 | |
| EP3646336B1 (en) | A system and a method for renal replacement therapy | |
| JP7227460B2 (ja) | 血液透析装置における補液通路の閉塞検出装置 | |
| JP2024517095A5 (cg-RX-API-DMAC7.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20231012 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250320 Comment text: Request for Examination of Application |